Volume 84, Issue 1, Pages (July 2013)

Slides:



Advertisements
Similar presentations
Volume 86, Issue 2, Pages (August 2014)
Advertisements

Optimization of pre-ESRD care: The key to improved dialysis outcomes
Volume 59, Issue 3, Pages (March 2001)
Volume 91, Issue 5, Pages (May 2017)
Volume 86, Issue 4, Pages (October 2014)
Linear and logistic regression analysis
Anemia management in chronic kidney disease
Red blood cell life span and ‘erythropoietin resistance’
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
C-reactive protein and dialysis access
Volume 55, Issue 2, Pages (February 1999)
Volume 65, Issue 2, Pages (February 2004)
The risk of hospitalization and modality failure with home dialysis
Volume 86, Issue 2, Pages (August 2014)
C-reactive protein and dialysis access
Volume 54, Issue 2, Pages (August 1998)
Volume 82, Issue 1, Pages (July 2012)
George A. Kaysen, Burl R. Don
Volume 84, Issue 4, Pages (October 2013)
Volume 76, Issue 10, Pages (November 2009)
Prediction of hypertension in chronic hemodialysis patients
Volume 80, Issue 9, Pages (November 2011)
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 91, Issue 5, Pages (May 2017)
Volume 77, Issue 2, Pages (January 2010)
Volume 88, Issue 5, Pages (November 2015)
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Volume 87, Issue 2, Pages (February 2015)
Volume 60, Issue 1, Pages (July 2001)
Volume 66, Issue 1, Pages (July 2004)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 76, Issue 10, Pages (November 2009)
Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS)  Michelle.
Volume 90, Issue 6, Pages (December 2016)
Volume 54, Issue 2, Pages (August 1998)
The calcium–phosphorus in guidelines for CKD-MBD
Blood pressure targets in hemodialysis patients
Volume 67, Pages S63-S68 (January 2005)
Volume 61, Issue 6, Pages (June 2002)
The dynamics of prognostic indicators: toward earlier identification of dialysis patients with a high risk of dying  Charles Chazot, Guillaume Jean  Kidney.
Prevention of biofilm formation in dialysis water treatment systems
Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner 
Volume 61, Issue 6, Pages (June 2002)
Alternate-day dialysis may be needed for hemodialysis patients
Hepatitis C treatment in patients with kidney disease
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
A man with a hole in his penis
Volume 58, Issue 1, Pages (July 2000)
Volume 74, Issue 8, Pages (October 2008)
Volume 63, Issue 1, Pages (January 2003)
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Carmine Zoccali, Francesca Mallamaci  Kidney International 
Why measure serum albumin levels?
The course of the remnant kidney model in mice
Volume 72, Issue 2, Pages (July 2007)
Volume 72, Issue 2, Pages (July 2007)
Volume 80, Issue 10, Pages (November 2011)
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
Volume 80, Issue 10, Pages (November 2011)
Volume 65, Issue 4, Pages (April 2004)
Volume 60, Issue 6, Pages (December 2001)
Importance of blood pressure control in hemodialysis patient survival
Volume 59, Issue 3, Pages (March 2001)
Antioxidant therapy in hemodialysis patients: a systematic review
Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system  Victoria A. Kumar, Margo A. Sidell,
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients  Bradley A. Ford, Charles S. Eby,
Characteristics of sudden death in hemodialysis patients
Presentation transcript:

Volume 84, Issue 1, Pages 149-157 (July 2013) Interdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to death  Len A. Usvyat, Claudia Barth, Inga Bayh, Michael Etter, Gero D. von Gersdorff, Aileen Grassmann, Adrian M. Guinsburg, Maggie Lam, Daniele Marcelli, Cristina Marelli, Laura Scatizzi, Mathias Schaller, Adam Tashman, Ted Toffelmire, Stephan Thijssen, Jeroen P. Kooman, Frank M. van der Sande, Nathan W. Levin, Yuedong Wang, Peter Kotanko  Kidney International  Volume 84, Issue 1, Pages 149-157 (July 2013) DOI: 10.1038/ki.2013.73 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Patient flowchart. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Mean serum albumin and 95% confidence interval. (a) Mean serum albumin and 95% confidence interval in female patients in the 104 weeks before death. The left panels show estimates of the partially conditional means with 95% confidence intervals, and the right panels show estimates of rate of change trajectories with 95% confidence intervals. (b) Mean serum albumin and 95% confidence interval in male patients in the 104 weeks before death. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Mean interdialytic weight gain (IDWG; expressed as percent of post-hemodialysis (post-HD) weight) and 95% confidence interval. (a) Mean interdialytic weight gain (IDWG; expressed as percent of post-hemodialysis (post-HD) weight) and 95% confidence interval in female patients in the 104 weeks before death. The left panels show estimates of the partially conditional means with 95% confidence intervals, and the right panels show estimates of rate of change. (b) Mean IDWG (expressed as percent of post-HD weight) and 95% confidence interval in male patients in the 104 weeks before death. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Mean pre-hemodialysis (pre-HD) systolic blood pressure (SBP) and 95% confidence intervals. (a) Mean pre-hemodialysis (pre-HD) systolic blood pressure (SBP) and 95% confidence intervals in female patients in the 104 weeks before death. The left panels show estimates of the partially conditional means with 95% confidence intervals, and the right panels show estimates of rate of change trajectories with 95% confidence intervals. (b) Mean pre-HD SBP and 95% confidence intervals in male patients in the 104 weeks before death. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Mean C-reactive protein (CRP) and 95% confidence intervals in the 104 weeks before death. The left panel shows estimates of the partially conditional means with 95% confidence intervals, and the right panel shows estimates of rate of change trajectories with 95% confidence intervals. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 6 Mean serum albumin and 95% confidence interval. (a) Mean serum albumin and 95% confidence interval in the 104 weeks from the start of dialysis in female patients who survived >4 years. The left panels show estimates of the partially conditional means and the right panels show estimates of rate of change trajectories with 95% confidence intervals. (b) Mean serum albumin and 95% confidence interval in the 104 weeks from the start of dialysis in male patients who survived >4 years. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 7 Mean interdialytic weight gain (IDWG; expressed as percent of post-hemodialysis (post-HD weight)) and 95% confidence interval. (a) Mean interdialytic weight gain (IDWG; expressed as percent of post-hemodialysis (post-HD weight)) and 95% confidence interval in the 104 weeks from the start of dialysis in female patients who survived >4 years. The left panels show estimates of the partially conditional means and the right panels show estimates of rate of change trajectories with 95% confidence intervals. (b) Mean IDWG (%) and 95% confidence interval in the 104 weeks from start of dialysis in male patients who survived >4 years. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 8 Mean pre-hemodialysis (pre-HD) systolic blood pressure (SBP) and 95% confidence interval. (a) Mean pre-hemodialysis (pre-HD) systolic blood pressure (SBP) and 95% confidence interval in the 104 weeks from the start of dialysis in female patients who survived >4 years. The left panels show estimates of the partially conditional means and the right panels show estimates of rate of change. (b) Mean pre-HD SBP and 95% confidence interval in the 104 weeks from the start of dialysis in male patients who survived >4 years. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 9 Mean C-reactive protein (CRP) and 95% confidence interval in the 104 weeks from the start of dialysis in patients who survived>4 years. The left panel shows estimates of the partially conditional means and the right panel shows estimates of rate of change. Kidney International 2013 84, 149-157DOI: (10.1038/ki.2013.73) Copyright © 2013 International Society of Nephrology Terms and Conditions